share

[7-(3-Methyl-1,2,4-Oxadiazol-5-Yl)[1,2,4]Triazolo[4,3-A]Pyridin-3-Yl]Aceticacid CAS NO 1338661-82-7


Unit Price:

CAS No.:1338661-82-7

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

[7-(3-Methyl-1,2,4-Oxadiazol-5-Yl)[1,2,4]Triazolo[4,3-A]Pyridin-3-Yl]Aceticacid is a high-purity, advanced pharmaceutical intermediate featuring a fused heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular interactions. It is primarily needed by research institutions, pharmaceutical development laboratories, and fine chemical manufacturers engaged in drug discovery and process chemistry.

Application

  • Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of investigational new drugs, especially those targeting kinase inhibition or other enzyme-related pathways.
  • Medicinal Chemistry Research: Used as a scaffold for structure-activity relationship (SAR) studies to optimize potency and selectivity of candidate molecules.
  • Biochemical Tool Compound: Employed in vitro to study specific biological mechanisms and validate novel therapeutic targets.
  • Fine Chemical Synthesis: Utilized in multi-step organic syntheses to construct complex molecules for agrochemical or material science applications.
  • Contract Research & Manufacturing (CRAM): Supplied to organizations providing custom synthesis and scale-up services for the life sciences industry.

Basic Information

Item Details
Product Name [7-(3-Methyl-1,2,4-Oxadiazol-5-Yl)[1,2,4]Triazolo[4,3-A]Pyridin-3-Yl]Aceticacid
CAS No. 1338661-82-7
Molecular Formula C11H8N6O3
Molecular Weight 272.22 g/mol
Synonyms 2-{7-[(3-Methyl-1,2,4-oxadiazol-5-yl)][1,2,4]triazolo[4,3-a]pyridin-3-yl}acetic acid; (7-(3-Methyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)acetic acid; 1338661-82-7; [1,2,4]Triazolo[4,3-a]pyridine-3-acetic acid, 7-(3-methyl-1,2,4-oxadiazol-5-yl)-; 7-(3-Methyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-ylacetic acid
EINECS Contact for details

Quality Control

Our [7-(3-Methyl-1,2,4-Oxadiazol-5-Yl)[1,2,4]Triazolo[4,3-A]Pyridin-3-Yl]Aceticacid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting the stringent requirements for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity (typically ≥95% by HPLC), residual solvents, and related substances is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). This compound is moisture-sensitive (hygroscopic); keep the container tightly sealed under an inert atmosphere if necessary to prevent degradation.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to structure
Identification (HPLC) Retention time matches reference
Purity (HPLC) ≥ 95.0%
Related Substances (HPLC) Total impurities ≤ 5.0%
Water Content (KF) ≤ 1.0%
Residual Solvents (GC) Complies with ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.